MSB 10.4% $1.49 mesoblast limited

Cell Therapy News/Articles, page-2572

  1. 58 Posts.
    lightbulb Created with Sketch. 11

    Mesoblast Sees Unusually High Options Volume (NASDAQ:MESO)

    Mesoblast limited (NASDAQ:MESO) was the target of unusually large options trading activity on Wednesday. Stock investors purchased 2,971 call options on the stock. This is an increase of 531% compared to the typical volume of 471 call options.

    Several large investors have recently modified their holdings of MESO. Penbrook Management LLC grew its position in Mesoblast by 3.9% during the fourth quarter. Penbrook Management LLC now owns 232,100 shares of the company’s stock valued at $1,711,000 after buying an additional 8,800 shares during the period. M&G Investment Management Ltd. purchased a new position in shares of Mesoblast during the 4th quarter worth $10,440,000. Tobias Financial Advisors Inc. purchased a new position in shares of Mesoblast during the 4th quarter worth $191,000. Wilbanks Smith & Thomas Asset Management LLC grew its position in shares of Mesoblast by 6.0% during the 4th quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 25,025 shares of the company’s stock valued at $184,000 after acquiring an additional 1,425 shares during the period. Finally, Ingalls & Snyder LLC purchased a new stake in shares of Mesoblast in the 1st quarter worth $53,000. Hedge funds and other institutional investors own 2.07% of the company’s stock.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.